Related Experiment Video
Updated: Aug 2, 2026

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells
Published on: February 21, 2018
Oncostatin M and leukemia inhibitory factor trigger overlapping and different signals through partially shared
B Thoma1, T A Bird, D J Friend
1Department of Biochemistry, Immunex Corporation, Seattle, Washington 98101.
Abstract:
Leukemia inhibitory factor (LIF) and oncostatin M (OSM) both bind to the same receptor with high affinity and thus mediate an overlapping spectrum of biological activities, the signal transduction mechanisms for which are unclear. We show that mitogen-activated protein kinases are involved in both the LIF and OSM signal transduction pathways. However, we found that OSM is a much more potent inducer of both mitogen-activated protein kinase activity and biological response, both of which correlate with the expression of a second OSM receptor that does not bind LIF. In addition, different patterns of tyrosine-phosphorylated proteins were stimulated by OSM and LIF. We therefore suggest that the two receptors for OSM can be coupled to different signal transduction events.
Insights
Leukemia inhibitory factor (LIF) and oncostatin M (OSM) share a receptor, but OSM more potently activates signaling pathways like mitogen-activated protein kinases. Different receptors for OSM suggest distinct signaling events.
Area of Science:
- Cellular signaling pathways
- Cytokine receptor interactions
- Molecular biology
Background:
- Leukemia inhibitory factor (LIF) and oncostatin M (OSM) are cytokines with overlapping biological activities.
- Both LIF and OSM bind to the same receptor with high affinity.
- The precise signal transduction mechanisms for LIF and OSM remain unclear.
Purpose of the Study:
- To investigate the signal transduction pathways of LIF and OSM.
- To compare the potency of OSM and LIF in inducing cellular responses.
- To explore the role of different receptors in OSM signaling.
Main Methods:
- Analysis of mitogen-activated protein kinase (MAPK) activation.
- Assessment of biological responses.
- Investigation of tyrosine-phosphorylated protein patterns.
- Receptor binding assays.
Main Results:
- Mitogen-activated protein kinases are involved in both LIF and OSM signaling.
- OSM is a more potent inducer of MAPK activity and biological responses compared to LIF.
- A second OSM receptor, distinct from the LIF-binding receptor, was identified and correlates with OSM's potent effects.
- LIF and OSM stimulate different patterns of tyrosine-phosphorylated proteins.
Conclusions:
- The findings suggest that OSM can utilize distinct receptors to initiate different signal transduction events.
- OSM exhibits greater potency in activating signaling pathways and cellular responses than LIF.
- Understanding these differential signaling mechanisms is crucial for deciphering cytokine function.
Related Concept Videos
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
Differentiation of Common Myeloid Progenitor Cells
Regulation of Hematopoietic Stem Cells
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
The JAK-STAT Signaling Pathway
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:

